Malaria Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Phase III Trial of R21/Matrix-M in African Children Against Clinical Malaria
Condition: Malaria Interventions: Biological: R21/Matrix-M; Biological: Rabies vaccine Sponsors: University of Oxford; Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN), Nanoro, Burkina Faso; Institut de Recherche en Sciences de la Sante-Direction Regionale de l'Ouest; Malaria Research and Training Center, Bamako, Mali; KEMRI-Wellcome Trust Collaborative Research Program; Ifakara Health Institute Clinical Trial Facility, Bagamoyo Research and Training Centre, PO Box 74, Bagamoyo, Tanzania; London School of Hygiene and Tropical Medicine Not ...
Source: ClinicalTrials.gov - January 12, 2021 Category: Research Source Type: clinical trials

R21/Matrix-M in African Children Against Clinical Malaria
Condition: Malaria Interventions: Biological: R21/Matrix-M; Biological: Rabies vaccine Sponsors: University of Oxford; Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN), Nanoro, Burkina Faso; Institut de Recherche en Sciences de la Sante-Direction Regionale de l'Ouest; Malaria Research and Training Center, Bamako, Mali; KEMRI-Wellcome Trust Collaborative Research Program; Ifakara Health Institute Clinical Trial Facility, Bagamoyo Research and Training Centre, PO Box 74, Bagamoyo, Tanzania; London School of Hygiene and Tropical Medicine Not ...
Source: ClinicalTrials.gov - January 12, 2021 Category: Research Source Type: clinical trials